NATURE. EDITORIAL. 23 December 2022. There’s no room for COVID complacency in 2023. Stark scenes from China show the pandemic is far from over.
NATURE. EDITORIAL. 23 December 2022. There’s no room for COVID complacency in [...]
GROUND TRUTHS. REPORT. DR ERIC TOPOL. Dec 23. A new variant alert The XBB.1.5 variant is on a growth spurt in the United States
GROUND TRUTHS. FOR EDUCATIONAL PURPOSES. As everyone who has been following [...]
BLOOMBERG. 21 December 2022. China’s Covid Tsunami [250 million in 20 days] Could Spark a Dangerous New Variant That Infects the World.
Bloomberg reports the tsunami of Covid-19 that’s taking hold across [...]
THE ROAD TO IRELAND VIDEO. Pharma’s Almanac. Nigel Walker Interviews Peter Jensen, CEO and Chairman of Normax (4:27)
Of about 10,000 diseases in humans, only 500 are [...]
-
REPORT. THE COMMONWEALTH FUND. YALE SCHOOL OF PUBLIC HEALTH. COVID-19 Vaccination program in U.S. saved 3.2 million lives and U.S. $1.15 trillion in 2 years GalleryREPORT. THE COMMONWEALTH FUND. YALE SCHOOL OF PUBLIC HEALTH. COVID-19 Vaccination program in U.S. saved 3.2 million lives and U.S. $1.15 trillion in 2 years
REPORT. THE COMMONWEALTH FUND. YALE SCHOOL OF PUBLIC HEALTH. COVID-19 Vaccination program in U.S. saved 3.2 million lives and U.S. $1.15 trillion in 2 years
Two Years of U.S. COVID-19 Vaccines Have Prevented Millions of [...]
REPORT. NATURE MEDICINE. COVID-19 VACCINE HOARDING estimated to have cost 1.3 MILLION DEATHS in developing countries.
Retrospectively modeling the effects of increased global vaccine sharing on [...]
Normax to invest €30,000,000 in first Vax Factory for mRNA vaccine manufacturing in Dublin, Ireland
Normax is building a path for rapid growth of [...]
-
NEWS. Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine – 04 NOV 2022 GalleryNEWS. Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine – 04 NOV 2022
-
BIOSECURITY VIEWPOINT. Dangerous, Continuous, Uncontrollable Global Evolution of Multiple SARS-CoV-2 “Variants of Concern” Toward Immune Escape with Unpredictable Long-term Consequences… GalleryBIOSECURITY VIEWPOINT. Dangerous, Continuous, Uncontrollable Global Evolution of Multiple SARS-CoV-2 “Variants of Concern” Toward Immune Escape with Unpredictable Long-term Consequences…